Evidence map›Paper›PMID 15479790›Full record

ArticleJournal of virology2004

Impact on genetic networks in human macrophages by a CCR5 strain of human immunodeficiency virus type 1.

Carter R Coberley, James J Kohler, Joseph N Brown, Joseph T Oshier, Henry V Baker, Michael P Popp, John W Sleasman, Maureen M Goodenow

Open access · greenAbstract read
In one paragraph

Article in Journal of virology, 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
0.6field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 38 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Δ(9)-Tetrahydrocannabinol treatment during human monocyte differentiation reduces macrophage susceptibility to HIV-1 infection.Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology · 2014
    Article
  9. Article
  10. Article
  11. Article
  12. Gene array studies in HIV-1 infection.Current HIV/AIDS reports · 2012
    Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Carter R CoberleyDepartment of Pathology, Immunology, and Laboratory Medicine, Box 100275, University of Florida College of Medicine, 1600 S.W. Archer Rd., Gainesville, FL 32610, USA.
James J Kohler
Joseph N Brown
Joseph T Oshier
Henry V Baker
Michael P Popp
John W Sleasman
Maureen M Goodenow
UF Health Cancer CenterUniversity of Florida · USUniversity of South Florida St. Petersburg · US

Funding

Human Immunodeficiency Virus ProteinaseR37AI028571 · NIAID · UNIVERSITY OF FLORIDA · PI DUNN, BEN M. · 2005 to 2014
$3.8M
TRAINING IN THE CELL BIOLOGY AND IMMUNOBIOLOGY OF CANCERT32CA009126 · NCI · UNIVERSITY OF FLORIDA · PI MAY, WILLIAM STRATFORD · 1985 to 2012
$3.5M
IMPACT OF HIV-1 GENOTYPE ON THERAPY RESPONSE IN CHILDRENR01AI047723 · NIAID · UNIVERSITY OF SOUTH FLORIDA · PI SLEASMAN, JOHN W. · 2001 to 2010
$3.3M
HIV-1 VARIANTS WITHIN PBMC SUBPOPULATIONS IN INFANTSR01HD032259 · NICHD · UNIVERSITY OF FLORIDA · PI GOODENOW, MAUREEN M · 1995 to 2007
$2.8M
IMMUNOLOGIC/GENETIC MECHANISMS IN RHEUMATIC DISEASEST32AR007603 · NIAMS · UNIVERSITY OF FLORIDA · PI REEVES, WESTLEY H · 1998 to 2014
$2.2M
HUMAN IMMUNODEFICIENCY VIRUS PROTEINASER01AI028571 · NIAID · UNIVERSITY OF FLORIDA · PI DUNN, BEN M. · 1989 to 2004
$1.3M
ACTIVATION OF HIV-1 IN MACROPHAGES BY LUNG CELLSR01HL058005 · NHLBI · UNIVERSITY OF FLORIDA · PI GOODENOW, MAUREEN M · 1996 to 2000
$290k
NCI NIH HHS T32 CA009126NCI NIH HHS T32 CA09126NHLBI NIH HHS HL58005NIAID NIH HHS AI28571NIAID NIH HHS AI47723NIAID NIH HHS R01 AI028571NIAID NIH HHS R01 AI047723NIAID NIH HHS R37 AI028571NIAMS NIH HHS T32 AR007603NIAMS NIH HHS T32 AR07603NICHD NIH HHS R01 HD032259NICHD NIH HHS R01 HD32259
6 · The paper itself

Abstract

Human immunodeficiency virus type 1 (HIV-1) impacts multiple lineages of hematopoietic cells, including lymphocytes and macrophages, either by direct infection or indirectly by perturbations of cell networks, leading to generalized immune deficiency. We designed a study to discover, in primary human macrophages, sentinel genetic targets that are impacted during replication over the course of 7 days by a CCR5-using virus. Expression of mRNA and proteins in virus- or mock-treated macrophages from multiple donors was evaluated. Hierarchical agglomerative cluster analysis grouped into distinct temporal expression patterns >900 known human genes that were induced or repressed at least fourfold by virus. Expression of more than one-third of the genes was induced rapidly by day 2 of infection, while other genes were induced at intermediate (day 4) or late (day 7) time points. More than 200 genes were expressed exclusively in either virus- or mock-treated macrophage cultures, independent of the donor, providing an unequivocal basis to distinguish an effect by virus. HIV-1 altered levels of mRNA and/or protein for diverse cellular programs in macrophages, including multiple genes that can contribute to a transition in the cell cycle from G(1) to G(2)/M, in contrast to expression in mock-treated macrophages of genes that maintain G(0)/G(1). Virus treatment activated mediators of cell cycling, including PP2A, which is impacted by Vpr, as well as GADD45 and BRCA1, potentially novel targets for HIV-1. The results identify interrelated programs conducive to optimal HIV-1 replication and expression of genes that can contribute to macrophage dysfunction.

Indexed as

Gene Expression RegulationCDC2 Protein KinaseCell CycleCells, CulturedHIV-1HumansLymphocytesMacrophagesReceptors, CCR5Virus ReplicationCDC2 Protein KinaseReceptors, CCR5

Identifiers

PMID15479790
PMCPMC523249
OpenAlexW2029928145

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.